Recurrent Primary Hepatic VIPoma Treated with a Combination of Surgical Resection and Loco-Regional Therapy [PDF]
Future Science OA, 2023 Vasoactive intestinal peptide (VIP) secreting tumors (VIPomas) are insidious functional neuroendocrine tumors originating mainly from pancreatic islet cells.
Wafa Dahmani +2 more
exaly +4 more sources
Case report: Resolution of VIPoma-related symptoms with peptide receptor radionuclide therapy [PDF]
Frontiers in OncologyPeptide receptor radionuclide therapy (PRRT) is used for the management of neuroendocrine tumors (NETs) not responsive to somatostatin analogs. In this case series, we report two patients with pancreatic vasoactive intestinal peptide (VIP)-secreting NETs
Edward Wolin
exaly +4 more sources
Hypercalcemia as the Presenting Finding in VIPoma [PDF]
Brown Journal of Hospital Medicine, 2023 Hypercalcemia is typically associated with primary hyperparathyroidism, malignancy, vitamin D intoxication, and granulomatous disease; however, it can also be associated with a neuroendocrine tumor that secretes vasoactive intestinal polypeptide (VIP). A
Olivia P Yang +4 more
doaj +5 more sources
Surgical treatment of metastatic VIPoma: a case report
Therapeutic Advances in Gastroenterology, 2021 VIPoma, a neuroendocrine tumour mostly occurring in the human pancreas and producing high levels of vasoactive intestinal peptide, is a rare disease that presents with a wide spectrum of symptoms, including intense diarrhoea, hypokalaemia, and cardiac ...
Azadeh Azizian +2 more
exaly +2 more sources
Chronic Diarrhea Caused by Vasoactive Intestinal Peptide-Secreting Tumor [PDF]
Life, 2023 VIPomas are a type of neuroendocrine tumor that independently produces vasoactive intestinal peptide (VIP). VIPomas causing watery diarrhea, hypokalemia, and achlorhydria (WDHA) syndrome are not frequently observed in adult patients without pancreatic ...
Oana Belei +8 more
doaj +2 more sources
Laparoscopic resection of VIPoma presenting at an unusual location
Journal of Minimal Access Surgery, 2022 VIPoma is an extremely rare neuroendocrine tumour. Majority of the lesions occur in the pancreas. There is usually a long and recurrent history of secretory diarrhoea. Current diagnostic methods help in diagnosing a VIPoma once it is suspected. We herein
Ravi Kiran Thota, Srikanth Gadiyaram
doaj +2 more sources
Vasoactive Intestinal Polypeptide Secreting MS Neuroblastoma
Journal of Indian Association of Pediatric SurgeonsWe present a rare case of a 17-month-old child diagnosed with MS-stage neuroblastoma and associated chronic diarrhea due to elevated vasoactive intestinal peptide (VIP) levels.
Josy Thomas +6 more
doaj +2 more sources
Sporadic pancreatic vasoactive intestinal peptide-producing tumor (VIPoma) in a 47-year-old male
Hematology/ Oncology and Stem Cell Therapy, 2014 VIPoma is an exceedingly unusual neuroendocrine neoplasm that autonomously secretes vasoactive intestinal polypeptide (VIP). Its reported incidence is approximately 1 per 10 million individuals per year.
Ahmed Abu-Zaid +2 more
exaly +3 more sources
Octreotide infusion pump in patients with functional neuroendocrine tumors and refractory hormonal syndrome [PDF]
Endocrine OncologyObjective: To evaluate clinical outcomes, safety and survival measures of octreotide infusion pump (OIP) therapy in patients with metastatic neuroendocrine tumors (NETs) and refractory hormonal syndrome.
Kalyan Mansukhbhai Shekhda +8 more
doaj +2 more sources
Characteristics, therapy, and outcome of rare functioning pancreatic neuroendocrine neoplasms [PDF]
Scientific ReportsFunctioning pancreatic neuroendocrine neoplasms other than insulinomas and gastrinomas (rf-pNENs) are exceptionally rare tumours. Thus, their characteristics and long-term prognosis have not been well defined.
Max B. Albers +6 more
doaj +2 more sources